Across TCGA pan-cancer cohorts, OR5AN2P RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of OR5AN2P’s most consistent transcriptional readouts.
The strongest signal is observed in thyroid carcinoma (THCA), where OR5AN2P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OR5AN2P is over-expressed in tumor.
THCA are the cancer types where OR5AN2P tumor–normal differential expression is most reproducible.